Affiliations 

  • 1 Faculty of Medicine and Health Sciences, Taiz University, Taiz 6803, Yemen
  • 2 Department of Emergency Medicine, E-Da Hospital, I-Shou University, No. 1, Yi-Da Road, Yanchao District, Kaohsiung City 824, Taiwan
  • 3 Department of Educational Psychology, Faculty of Education, Taiz University, Taiz 6803, Yemen
  • 4 Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Malaya, Kuala Lumpur 50603, Malaysia
  • 5 Department of Pharmacology, Faculty of Pharmacy, Sana'a University, Mazbah District, Sana'a 1247, Yemen
  • 6 Department of Biomedical Sciences, College of Health Sciences, QU-Health, Qatar University, Doha 2713, Qatar
  • 7 Department of Community Health, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang 43300, Malaysia
  • 8 Migration Health Division, International Organization for Migration (IOM), Amman 11953, Jordan
  • 9 Department of Clinical Pharmacy and Practice, College of Pharmacy, QU-Health, Qatar University, Doha 2713, Qatar
  • 10 Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan
Healthcare (Basel), 2022 Sep 24;10(10).
PMID: 36292305 DOI: 10.3390/healthcare10101858

Abstract

BACKGROUND: Several instruments are currently used to assess Coronavirus Disease 2019 (COVID-19) -induced psychological distress, including the 22-item Impact of Event Scale-Revised (IES-R). The IES-R is a self-administered scale used to assess post-traumatic stress disorder (PTSD). The current study aimed to examine the construct validity of the IES-R, based on the Rasch model, with COVID-19-related data, as well as to test the multilevel construct validity of the IES-R within and among countries during the pandemic crisis.

METHODS: A multi-country web-based cross-sectional survey was conducted utilizing the 22-item IES-R. A total of 1020 participants enrolled in our survey, of whom 999 were included in the analyses. Data were analyzed using Rasch modeling and multilevel confirmatory factor analysis (MCFA).

RESULTS: The Rasch modeling results of the IES-R demonstrated that the IES-R is a satisfactory instrument with the five-point Likert scale, asserting that its 22 items are significant contributors to assessing PTSD as a unidimensional construct covered by the items of the IES-R. The MCFA confirmed that the 22-item IES-R, with its three factors, including intrusion, avoidance, and hyperarousal, demonstrates adequate construct validity at the within- and among-country levels. However, the results of the Akaike information criterion (AIC) model determined that the 16-item IES-R is better than the 22-item IES-R.

CONCLUSION: The results suggested that the 22-item IES-R is a reliable screening instrument for measuring PTSD related to the COVID-19 pandemic, and can be utilized to provide timely psychological health support, when needed, based on the screening results.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications